Microsomal ethanol oxidizing system: transcriptional and posttranscriptional regulation of cytochrome P450, CYP2E1
- PMID: 1845601
Microsomal ethanol oxidizing system: transcriptional and posttranscriptional regulation of cytochrome P450, CYP2E1
Abstract
CYP2E1 is solely responsible for microsomal P450-mediated ethanol oxidation activity. This enzyme is also involved in a pathway leading to gluconeogenesis from ketone bodies and in metabolic activation of numerous foreign compounds to intermediates that can be toxic to cells. Metabolic activation of certain procarcinogens by CYP2E1 may also lead to cell transformation. Regulation of CYP2E1 is especially intriguing. The CYP2E1 gene is transcriptionally activated in rat liver from a dormant state within a few hours after birth. This activation is due in part to the participation of a transcription factor designated hepatocyte nuclear factor 1 or HNF-1. In adult animals, constitutive expression of the enzyme is controlled to some degree by growth hormone. CYP2E1 is also regulated by many of its substrates through a substrate-induced stabilization of the enzyme. Under extreme conditions of fasting and uncontrolled diabetes CYP2E1 mRNA is stabilized.
Similar articles
-
Transcriptional and posttranscriptional regulation of CYP2E1, an N-nitrosodimethylamine demethylase.Princess Takamatsu Symp. 1990;21:157-64. Princess Takamatsu Symp. 1990. PMID: 2134674 Review.
-
Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes.Mol Pharmacol. 1996 Feb;49(2):260-8. Mol Pharmacol. 1996. PMID: 8632758
-
Expression of cytochrome P4502E1 in rat fetal hepatocyte culture.Mol Pharmacol. 1996 May;49(5):802-7. Mol Pharmacol. 1996. PMID: 8622629
-
Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors.Hepatology. 1995 Jun;21(6):1610-7. Hepatology. 1995. PMID: 7768506
-
Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease.Alcohol. 1993 Nov-Dec;10(6):447-52. doi: 10.1016/0741-8329(93)90063-t. Alcohol. 1993. PMID: 8123198 Review.
Cited by
-
Polymorphisms of ethanol-oxidizing enzymes in alcoholics with inactive ALDH2.Hum Genet. 1996 Apr;97(4):431-4. doi: 10.1007/BF02267061. Hum Genet. 1996. PMID: 8834237
-
Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells.Exp Biol Med (Maywood). 2010 Jan;235(1):32-9. doi: 10.1258/ebm.2009.009252. Exp Biol Med (Maywood). 2010. PMID: 20404016 Free PMC article.
-
Molecular cloning and expression of novel alternatively spliced cytochrome P450 2E1 mRNAs in humans.Mol Cell Biochem. 2005 Dec;280(1-2):201-7. doi: 10.1007/s11010-005-0169-x. Mol Cell Biochem. 2005. PMID: 16311924
-
The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms.Int J Mol Sci. 2021 Aug 6;22(16):8447. doi: 10.3390/ijms22168447. Int J Mol Sci. 2021. PMID: 34445153 Free PMC article.
-
Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.Clin Pharmacokinet. 2003;42(1):1-31. doi: 10.2165/00003088-200342010-00001. Clin Pharmacokinet. 2003. PMID: 12489977 Review.